2.0200
-0.0700
(-3.35%)
At close: January 10 at 4:00:01 PM EST
2.0200
0.00
(0.00%)
After hours: January 10 at 5:01:17 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 2 |
| Avg. Estimate | -0.27 | 0 | -2.1 | -1.59 |
| Low Estimate | -0.27 | 0 | -2.1 | -1.65 |
| High Estimate | -0.27 | 0 | -2.1 | -1.52 |
| Year Ago EPS | -1.5 | -- | -7.62 | -2.1 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.65 | -1.05 | -0.45 | -0.7 |
| EPS Actual | -1.5 | -0.75 | -0.6 | -0.51 |
| Difference | 0.15 | 0.3 | -0.15 | 0.19 |
| Surprise % | 9.09% | 28.57% | -33.33% | 27.14% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.27 | 0 | -2.1 | -1.59 |
| 7 Days Ago | -0.28 | 0 | -2.31 | -1.64 |
| 30 Days Ago | -0.28 | 0 | -2.31 | -1.64 |
| 60 Days Ago | -0.6 | 0 | -2.55 | -2.47 |
| 90 Days Ago | -0.6 | 0 | -2.55 | -2.47 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BCLI | 82.00% | -- | 72.45% | 24.52% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Upgrade | Maxim Group: Hold to Buy | 7/11/2024 |
| Downgrade | Maxim Group: Buy to Hold | 9/28/2023 |
| Maintains | Maxim Group: Buy | 3/31/2023 |
| Upgrade | Maxim Group: Hold to Buy | 2/5/2021 |
| Initiated | HC Wainwright & Co.: Buy | 5/15/2018 |
| Maintains | Maxim Group: Buy | 8/17/2017 |
Related Tickers
PLUR Pluri Inc.
4.2400
-2.30%
BLRX BioLineRx Ltd.
0.1429
+0.21%
BONS.TA Bonus BioGroup Ltd.
15.50
+2.65%
THTX Theratechnologies Inc.
1.8700
-6.27%
MNPR Monopar Therapeutics Inc.
25.35
+3.64%
VRCA Verrica Pharmaceuticals Inc.
0.6601
-5.66%
CANF Can-Fite BioPharma Ltd.
1.5800
+0.64%
AMLX Amylyx Pharmaceuticals, Inc.
3.5000
-7.16%
ACET Adicet Bio, Inc.
0.9171
-4.47%
CDTX Cidara Therapeutics, Inc.
24.00
-3.54%